✦ LIBER ✦

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

✍ Scribed by Matthew R Smith; Fred Saad; Robert Coleman; Neal Shore; Karim Fizazi; Bertrand Tombal; Kurt Miller; Paul Sieber; Lawrence Karsh; Ronaldo Damião; Teuvo L Tammela; Blair Egerdie; Hendrik Van Poppel; Joseph Chin; Juan Morote; Francisco Gómez-Veiga; Tomasz Borkowski; Zhishen Ye; Amy Kupic; Roger Dansey; Carsten Goessl

Book ID: 117309034
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 216 KB
Volume: 379
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(11)61226-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Denosumab and Bone-Metastasis-Free S

Re: Denosumab and Bone-Metastasis-Free Survival in Men With Castration-Resistant Prostate Cancer: Results of a Phase 3, Randomised, Placebo-Controlled Trial

✍ Walsh, Patrick C. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 115 KB

Denosumab versus zoledronic acid in pati

Denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer: Results from a phase 3 randomized trial

✍ J. Brown*; M. Carducci; K. Fizazi; M. Smith; R. Damião; L. Karsh; P. Milecki; H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

PCN9 Modeling Lifetime Effectiveness of

PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)

✍ M. Lothgren; G. Hechmati; I. Jacobs; Y. Qian; J. Arellano 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Phase 3, randomized, placebo-controlled

Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone

✍ Joel B. Nelson; Karim Fizazi; Kurt Miller; Celestia Higano; Judd W. Moul; Hideyu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 846 KB

Re: Denosumab Versus Zoledronic Acid for

Re: Denosumab Versus Zoledronic Acid for Treatment of Bone Metastases in Men With Castration-Resistant Prostate Cancer: A Randomised, Double-Blind Study

✍ Walsh, Patrick C. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 110 KB

Serum alkaline phosphatase changes predi

Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy

✍ Sonpavde, Guru; Pond, Gregory R.; Berry, William R.; de Wit, Ronald; Armstrong, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 531 KB